Inhibition of TREM-1 and Dectin-1 Alleviates the Severity of Fungal Keratitis by Modulating Innate Immune Responses

PLoS One. 2016 Mar 10;11(3):e0150114. doi: 10.1371/journal.pone.0150114. eCollection 2016.

Abstract

Purpose: To explore the possibility that inhibiting triggering receptor expressed on myeloid cells-1 (TREM-1) and Dendritic cell-associated C-type lectin-1(Dectin-1) could modulate the innate immune response and alleviate the severity of corneal fungal keratitis.

Method: TREM-1 and Dectin-1 expression was detected in fungus-infected human corneal specimens by real-time PCR. C57BL/6 (B6) mice were injected with Aspergillus fumigatus and divided into 4 groups that received subconjunctival injections of PBS and IgG as a control (group I), mTREM-1/IgG fusion protein (group II), the soluble β-glucan antagonist laminarin (group III), or mTREM-1/Fc and laminarin (group IV). Corneal virulence was evaluated based on clinical scores. TREM-1 and Dectin-1 mRNA levels were assayed using real-time PCR. The distribution patterns of TREM-1, Dectin-1 and cellular infiltrates in fungus-infected corneas were examined by immunohistochemistry. Moreover, changes in T Helper Type1 (Th1)-/ T Helper Type1 (Th2)- type cytokines and proinflammatory cytokines were measured.

Results: The expression of TREM-1 and Dectin-1 increased significantly and correlated positively with the progression of fungal keratitis. Most infiltrated cells were neutrophils and secondarily macrophages in infected cornea. The clinical scores decreased after interfering with TREM-1 and Dectin-1 expression in infected mouse corneas. Levels of Th1-type cytokines including interleukin-12 (IL-12), IL-18 and interferon-γ (IFN-γ) were decreased in the cornea, while the levels of Th2-type cytokines, including IL-4, IL-5 and IL-10, showed obvious increases.

Conclusion: TREM-1 and Dectin-1 function concurrently in the corneal innate immune response by regulating inflammatory cytokine expression in fungal keratitis. Inhibition of TREM-1 and Dectin-1 can alleviate the severity of corneal damage by downregulating the excessive inflammatory response.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • Aspergillosis* / immunology
  • Aspergillosis* / pathology
  • Aspergillus fumigatus / immunology*
  • Cornea / immunology
  • Cornea / pathology
  • Cytokines / immunology
  • Female
  • Humans
  • Immunity, Innate*
  • Keratitis* / immunology
  • Keratitis* / microbiology
  • Keratitis* / pathology
  • Lectins, C-Type* / antagonists & inhibitors
  • Lectins, C-Type* / immunology
  • Male
  • Membrane Glycoproteins* / antagonists & inhibitors
  • Membrane Glycoproteins* / immunology
  • Mice
  • Middle Aged
  • Receptors, Immunologic* / antagonists & inhibitors
  • Receptors, Immunologic* / immunology
  • Severity of Illness Index
  • Th1 Cells / immunology
  • Th1 Cells / pathology
  • Th2 Cells / immunology
  • Th2 Cells / pathology
  • Triggering Receptor Expressed on Myeloid Cells-1

Substances

  • CLEC7A protein, human
  • Cytokines
  • Lectins, C-Type
  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TREM1 protein, human
  • TREM1 protein, mouse
  • Triggering Receptor Expressed on Myeloid Cells-1

Grants and funding

This investigation was supported by grants from the National Natural Science Foundation of China to JY (81270972) and XH (U0832006); the fund of young prominent scholars of Sun Yat-sen University to JY (grant 11ykpy66); and the Guangdong Innovative Research Team Program to XH (2009010058).